Sobi: Presentation of Q4 and Full Year 2011 results
(Thomson Reuters ONE) -
Sobi's interim report for the fourth quarter and full year 2011 will be
published on 23 February 2012 at 8.30 a.m. CET.
Conference call at 3.00 p.m. CET
Financial analysts and media are invited to a telephone conference at 3.00 p.m.
CET the same day hosted by CEO Geoffrey McDonough and CFO Lars Sandström. The
presentation will be held in English and can be followed live or afterwards on
our web sitewww.sobi.com.
Slides used in the presentation will be available on our web site prior to the
telephone conference.
Details for participation
Please call:
SE: +46 (0)8 505 598 09
UK: +44 (0)207 750 99 50
US: +1 866 676 58 69
Yours sincerely,
Åsa Stenqvist,
VP Communications and Investor Relations (Acting)
Phone: +46 8 697 21 88
About Swedish Orphan Biovitrum (Sobi)
Sobi is a leading integrated biopharmaceutical company dedicated to bringing
innovative therapies and services to improve the health of rare disease patients
and their families. The product portfolio comprises about 60 marketed products
as well as projects in the late clinical phase. Key therapeutic areas are
Inflammation and Genetics & Metabolism. In 2010 Sobi had revenues of SEK 1.9
billion and around 500 employees. The share (STO: SOBI) is listed on OMX NASDAQ
Stockholm. More information is available atwww.sobi.com.
Invitations- Q4 and Full Year 2011 Results:
http://hugin.info/134557/R/1587194/497848.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1587194]
Unternehmensinformation / Kurzprofil:
Datum: 17.02.2012 - 17:16 Uhr
Sprache: Deutsch
News-ID 116149
Anzahl Zeichen: 2269
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 154 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sobi: Presentation of Q4 and Full Year 2011 results"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
